Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Micro-X Ltd. ( (AU:MX1) ).
Micro-X Limited has released a presentation covering its financial results and operational update for the half year ended 31 December 2025. The document, approved by the board, is positioned as a high-level summary of the company’s assets, liabilities and performance, and refers investors to formal regulatory filings for comprehensive detail.
The company emphasises that the presentation is not an offer of securities or investment advice and highlights legal restrictions on distribution and sale, particularly in the United States. It also underscores that any forward-looking information is subject to uncertainty and risk, placing responsibility on investors to conduct their own analysis and seek professional advice before making investment decisions.
The most recent analyst rating on (AU:MX1) stock is a Sell with a A$0.07 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Ltd., listed on the ASX under ticker MX1, operates in the medical and imaging technology sector. The company develops and commercialises advanced X-ray systems leveraging innovative engineering to serve healthcare and related markets, with a focus on improving diagnostic capabilities and operational efficiency for end users.
Average Trading Volume: 224,541
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$50.83M
For an in-depth examination of MX1 stock, go to TipRanks’ Overview page.